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Clinical Research
Bariatric surgery emerged as a treatment for class III obesity 
more than 50 years ago, and since then, the number of opera-
tions performed has grown steadily.1 Surgical intervention 
using Roux-en-Y gastric bypass (RYGB) leads to a significant 
loss of excess weight.2 However, it can have a negative impact 
on the patient’s oral health status because gastrointestinal com-
plications, food intolerance, inadequate absorption of nutri-
ents, and/or vitamin supplementation can occur in the 
postoperative period.2-4
Persistent vomiting is also observed in patients who have 
undergone bariatric surgery, especially with a restrictive proce-
dure.5 Gastroesophageal reflux and vomiting alter the oral micro-
biota and pH, producing an acid oral environment, which 
facilitates dental erosion, hypersensitivity, and the development of 
carious lesions.4 Further-more, saliva flow appears to be reduced 
in obese individuals,6 which impedes the removal of cariogenic 
microorganisms from the mouth and affects the processes of den-
tal demineralization and remineralization.7
The inadequate absorption of nutrients is among the 
main postoperative complications of RYGB.8 Malabsorption, 
together with limited intake, contributes to a deficiency of 
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Abstract
Background: Bariatric surgery influences the intake and absorption of nutrients. The serum concentrations of vitamin C, myeloperoxidase 
(MPO) and oral clinical manifestations were examined in patients two years after Roux-en-Y gastric bypass (RYGB). Methods: Clinical 
prospective-study with control-group (CG; n = 26), assessed only once, and the bariatric-group (BG; n = 26), assessed in the basal period and 
at 12 and 24 months after surgery. The mean ages in the CG and BG were 37.8 ± 1.51 and 39.6 ± 1.93 years, respectively, and their body 
mass indices were 22.07 ± 0.29 and 45.62 ± 1.46 kg/m2, respectively. Results: At 12 months after surgery, increased episodes of vomiting 
(P < .001) and dental hypersensitivity (P= .012) were observed, with a reduction in the saliva buffering capacity of 21.3  2.9% (P= .004). 
At 24 months after RYGB, we detected a significant reduction in serum vitamin C (32.9 ± 5.3%, P < .001) and MPO values were higher 
than in the basal period (P = .032). With regard to oral hygiene habits, 92.3% of patients reported frequent tooth brushing and 96.1% used 
fluoride, which were similar across the two years. However, dental hypersensitivity (P = .048) was significantly increased than baseline. 
Conclusions: The results demonstrated that vitamin C deficiency and increased vomiting after RYGB for morbid obesity may contribute 
to increased periodontal disease. The fact it is impossible to determine which factors (diet, poor compliance with supplementation, vomit-
ing, poor oral hygiene) contributed to the dental problems in these patients is a shortcoming of the report. (Nutr Clin Pract. 
2012;27:114-121)
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vitamins, including B
12
, E, and C.8,9 As well as causing other 
problems, a lack of vitamin C can compromise the formation of 
collagen and subsequent tissue repair in the teeth and gums, trig-
gering bleeding of the gums and altering dental mobility.10,11 
Moreover, several studies have shown that reduced plasma lev-
els of vitamin C contribute to the development of periodontitis 
by favoring bacterial colonization of the gingival tissue.12,13
The fact that obesity is associated with chronic inflammation 
may also be reflected in oral disease.14 The greater infiltration of 
leukocytes and the local release of cytokines in inflamed tissues 
facilitate the development of periodontal disease, which is also 
more prevalent in obese patients than in the general population.14,15 
Myeloperoxidase (MPO), an enzyme abundant in the azurophilic 
granules of neutrophils, can be considered a biomarker of cellular 
infiltration of the gingival tissue in periodontal disease,16 and in this 
context, individuals with periodontal disease exhibit a significant 
increase in MPO activity.17
Because inflammation influences the development of dis-
ease in the oral cavity4 and bariatric surgery alters patient 
homeostasis, we investigated the influence of RYGB surgery 
on vitamin C and MPO levels and disease development in the 
oral cavity.
Materials and Methods
Study Outline
This was a clinical, prospective study (April 2007 to October 
2009) carried out at the University Hospital of the Federal Univer-
sity of Santa Catarina (UH-UFSC), Florianópolis, Brazil, after 
approval was given by the Committee for Ethics in Research With 
Humans at UFSC (#72/06). The study was registered on the Aus-
tralian New Zealand Clinical Trials Registry (ACTRN: 
ACTRN12610000905066) and conformed to the World Medical 
Association Declaration of Helsinki.18 All participants signed a 
term of free and informed consent.
Participants
The control group (CG) was assessed only once, whereas the 
bariatric group (BG) was assessed in the presurgical period 
(basal) and at 12 and 24 months after surgery. The CG com-
prised 26 individuals (4 men and 22 women), with a mean age 
of 37.9 ± 1.51 years and a body mass index (BMI) of 22.07 ± 
0.29 kg/m2, and was matched by gender and age to the BG. The 
inclusion criterion for the CG was normal weight, as defined by 
the World Health Organization (WHO),19 and the exclusion cri-
teria for the CG were infection; anemia; cardiovascular or neu-
rological disease; signs or symptoms of inflammation in the 
gingival tissue; renal insufficiency; diabetes mellitus or glucose 
intolerance; psychiatric or autoimmune disease; the use of anti-
biotics, immunosuppressants, antirheumatics, anti-inflamma-
tory drugs, and nutrition and/or hormonal supplements in the 6 
months before the study; alcohol dependence; smoking; and 
current menstruation. The BG sample consisted of 26 patients 
who had undergone RYGB (4 men and 22 women) with a mean 
age of 39.6 ± 1.93 years and a BMI of 45.62 ± 1.46 kg/m2. The 
inclusion criteria for the BG were age 20–59 years and BMI 
≥40 kg/m2 or ≥35 kg/m2 with a comorbidity, and the exclusion 
criteria for the BG were insulin use, immunosuppressant use, 
anti-inflammatory and/or immunosuppressant therapies, smok-
ing, alcohol dependence, rheumatoid arthritis, autoimmune 
disease, and/or a major psychiatric disorder.
Assessment of Nutrition Status and 
Consumption of Vitamin C
The BMI was calculated as the ratio of the weight (kg) to the 
height squared (m2). The weight and height were first deter-
mined using techniques recommended by WHO.19 The dietary 
consumption data were acquired by the administration of a 
validated, semiquantitative food frequency questionnaire.20 In 
this evaluation, supplementation with 60 mg/d vitamin C was 
taken into account (Centrum; Wyeth, São Paulo, SP, Brazil), 
according to the protocol developed by the UH-UFSC.
Saliva Parameters
This test was performed using the Dentobuff kit (Inodon, Porto 
Alegre, RS/Brazil). Before sampling, the patients were instructed 
to avoid eating, drinking, and tooth brushing for 2 hours. During 
sampling, the patient was instructed to chew a piece of unfla-
voured paraffin, collecting the saliva in a suitable vessel. Saliva 
flow was calculated from the volume of saliva produced in 5 min-
utes and was considered normal at a value ≥1 mL/min. The buff-
ering capacity of the saliva, determined by adding 1.5 mL of 
saliva to a tube containing a solution of 0.002 N hydrochloric acid 
and 4 drops of a chromogenic indicator, was classified as follows: 
low, pH <4.5; intermediate, pH 4.5–5.5; and normal, pH >5.5.
Assessment of Oral Clinical Manifestations 
and Oral Hygiene Habits
An oral health assessment of each patient was made during an 
interview conducted by clinically trained interviewers, accord-
ing to WHO.21 The structured questions used were validated 
and presented in Project SB–2003–Ministry of Health (2004),22 
Brazil. The symptoms of oral health assessed before and after 
surgery were the presence of gingivitis and periodontitis, 
according to WHO21 (bleeding of the gums when brushing 
and/or eating hard, dry foods; pain in the gums; and teeth with 
altered mobility); nausea; episodes of regurgitation; number of 
episodes of vomiting per day; tooth pain; and dental hypersen-
sitivity (sensitivity to cold). Oral hygiene habits were assessed 
as the frequency of tooth brushing, the use of dental floss 
and fluoride, and dentist visits and their reasons, during the 
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past 12 months, preceding the interview. The participants did 
not undergo a clinical periodontal examination.
Vitamin C and MPO Activity
After a 12-hour fast, blood was collected from the intermediate 
vein of the forearm by trained individuals. The concentration 
of vitamin C was determined according to the Bessey method23 
(UV–Vis Q-108U spectrophotometer; Quimis Aparelhos Cien-
tificos LTDA, Diadema, SP, Brazil). The results are expressed 
in mg/dL. MPO was quantified in the serum according to Rao 
et al,24 and the optical densities (absorbance at 520 nm) were 
read on an enzyme-linked immunosorbent assay plate reader 
(Organon Teknika, Roseland, NJ). The results are expressed in 
mU/mL.
Statistical Analysis
The data are presented as percentages, means, and standard 
errors of the means (SEM). The data were analyzed with the 
χ2 test, followed by Fisher exact test when appropriate. The 
Kruskal-Wallis test was followed by the Mann-Whitney test 
using statistical program Statistical Package for the Social 
Sciences (SPSS) for Windows, version 16.0 (SPSS, Inc, an 
IBM Company, Chicago, IL). A value of P < .05 was consid-
ered statistically significant.
Results
The mean basal weight in the BG was 120.6 ± 4.30 kg, and this 
was significantly reduced 24 months after surgery to 74.70 ± 
2.17 kg (P < .001). The basal BMI of 45.62 ± 1.46 kg/m2 had 
decreased significantly to 28.57 ± 0.77 kg/m2 (P < .001) at 24 
months and, by the end of the study, showed a reduction of 
36.50% ± 1.97% compared with that at the beginning of the 
study. A lower intake of vitamin C was observed after surgery 
compared with that in the basal period, even with supplemen-
tation. Vitamin C consumption at 12 months had decreased by 
16.46% ± 3.32% (P < .001), and at 24 months after surgery, it 
was 13.66% ± 9.82% (P = .005) lower than in the basal period 
(Table 1).
The basal serum concentration of vitamin C in the BG 
was significantly lower (41.6% ± 4.0%) than in the CG. 
There was a significant increase of 208.9% ± 25.6% in the 
serum vitamin C concentration at 12 months (P < .001), 
whereas at 24 months, this parameter had decreased by 
32.9% ± 5.3% compared with the basal level, despite supple-
mentation (P < .001). The basal values for MPO in the BG 
were higher than in the CG. At 12 months, a reduction of 
7.6% ± 6.8% (P = .096) was seen in MPO activity in the BG, 
with an increase at 24 months (23.7% ± 9.0%, P = .032) after 
surgery compared with the basal level (Table 1).
Saliva flow was significantly reduced in the basal period in 
the BG compared with that in the CG (P < .001). At 24 months 
after surgery, saliva flow was significantly higher compared 
with the basal period (P < .001). The basal-buffering capacity 
of saliva in the BG was above the reference value, although it 
was not significantly different from that of the CG (P = .090). 
At 12 months, this parameter was significantly reduced by 
21.3% ± 2.9% (P = .004) in the BG and was classified as inter-
mediate (Table 1).
The compliance with vitamin C supplementation, clinical 
manifestations in the oral cavity, and oral hygiene habits assessed 
in the CG and BG before and after surgery are given in Table 2. 
Two years after RYGB, the reported compliance with vitamin C 
supplementation was significantly reduced (12 months = 88.5%, 
χ2 = 41.241, P < .001 and 24 months = 69.2%, χ2 = 27.529, P < 
.001). One year after RYGB, there were significantly increased 
reports of pain and bleeding gums (26.9%, χ2 = 1.038, P = .499), 
hypersensitive teeth (42.3%, χ2 = 6.256, P = .012), and tooth pain 
(23.1%, χ2 = 2.641, P = .099). The prevalence of vomiting was 
92.3% (n = 24, χ2 = 28.144, P < .001), and the prevalence of vom-
iting 2 or more times daily was 76.9% (χ2 = 32.500, P < .001) at 1 
year after gastric bypass. Vomiting still occurred in 65.4% of 
patients (n = 17, χ2 = 11.345, P = .001) after 2 years. Only 7.7% (n 
= 2) of BG individuals did not experience vomiting during any of 
the postoperative period investigated. Two years after RYGB, the 
frequencies of nausea, regurgitation, bleeding of the gums, and 
hypersensitive teeth were 30.8%, 23.1%, 34.6%, and 34.6%, 
respectively, but these were not significantly different from the 
basal levels, except for hypersensitive teeth (χ2 = 3.900, P = .048). 
The presence of teeth with altered mobility was more prevalent at 
24 months than at baseline (19.2% and 3.8%, respectively).
The reported oral hygiene habits 2 years after RYGB were 
similar to the basal levels in terms of the frequency of tooth 
brushing (92.3%) and the use of fluoride (96.1%), but there 
was a significant increase in the use of dental floss (69.2%, χ2 
= 7.692, P = .006). Visiting the dentist was not reported by 
57.7% of the BG, which was significantly different from the 
rate in the CG (P < .001). However, 24 months after surgery, 
there was an increase in reported visits to the dentist (69.2%, χ2 
= 3.820, P = .051) compared with those in the basal period. 
Oral problems were reported to be the reason for visiting the 
dentist by 53.8% of BG patients, which was not significantly 
different from those reported in the basal period (Table 2).
Discussion
The RYGB surgical procedure involves a restrictive technique 
in which the gastric capacity is reduced, and vomiting is one of 
the main complications observed at postsurgical follow-
up.3,4,6,25 In this study, the prevalence of vomiting after surgery 
was markedly elevated compared with that in the basal period. 
This symptom contributes, in turn, to the development of den-
tal hypersensitivity,4,26 which was observed at 12 and 24 
months after RYGB.
The prolonged acid attacks on the teeth caused by vomiting 
can be accompanied by changes in the oral buffering 
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capacity.7,27,28 A reduction in the saliva-buffering capacity can 
then reduce the activity of the enzyme α-amylase, leading to an 
average reduction of 30%–40% in polysaccharide hydroly-
sis.29,30 The association of these events and the preference 
among individuals undergoing RYGB for foods that are easy to 
chew, such as those high in carbohydrates and sugars, may 
have a negative impact on weight loss.27,31
The number of patients presenting with hyposalivation was 
high, although saliva flow normalized after RYGB. Similarly, 
another study found that as the BMI increased, the saliva flow 
decreased, and the researchers explained this finding as a conse-
quence of medication32,33 and the nutrition deficit induced by a 
diet rich in simple carbohydrates and fat.11,33
In the postoperative period, we observed a lower dietary 
intake of ascorbic acid and inadequate supplementation, espe-
cially at 2 years after RYGB, which is supported by other stud-
ies.8,9,34 Of 26 patients evaluated, 3 reported that they had not 
taken the supplements because they were feeling well, and 5 
other patients reported that they kept forgetting to take their 
supplements on a daily basis. Inflammatory processes and oxi-
dative stress also may contribute to deficiency of vitamins, 
with an antioxidant function aggravated in the case of obese 
patients. Moreover, the deficiency of vitamins with an antioxi-
dant function, such as vitamin C, may be an incidental postop-
erative complication, with the severity being proportional to 
the extent of the reduction in the area for absorption,9 but that 
is not related only to the food intake.14,34
Vitamin C deficiency may affect the process of hydroxyl-
ation in the formation of hydroxyproline, an integral constituent 
of collagen, which can manifest as gingival bleeding and edema. 
However, when this deficiency is more severe, it leads to the 
loss of dental elements.13,35,36 In our analysis, the serum concen-
trations of vitamin C at 24 months were outside the reference 
range (0.6–2.0 mg/dL),37 which can result in systemic damage, 
thereby increasing the fragility of the dental tissue.36 Linked to 
this finding, MPO activity and visits to the dentist increased at 
this time point. Despite the limitations of this study, including 
the absence of a dental examination at follow-up, we observed a 
high incidence of vomiting and nausea and low compliance with 
vitamin C supplementation (30.8% noncompliance in the BG 2 
years after RYGB) in this cohort, which may have been associ-
ated with the observed low vitamin C and increased MPO. It has 
also recently been demonstrated that inadequate blood concen-
trations of vitamin C lead to greater susceptibility to periodonti-
tis, caused mainly by the reduced proliferation of fibroblasts and 
the lowered resistance of the host.38 Pussinen et al35 observed the 
inverse association between plasma vitamin C concentrations 
(1.4 ± 1.8 mg/L) and Porphyromonas gingivalis antibody levels. 
Staudte et al12 found that individuals with mean plasma ascorbic 
acid levels of 0.47 mg/dL, below the normal range, had increased 
bleeding scores, which may be related to the role of vitamin C in 
maintaining the microvasculature structure within the sulcus.
In the present study, the observed weight loss was not 
reflected in an increase in the concentration of inflammatory 
markers at 24 months, inconsistent with other studies.14,39-42 
Taking into account this result, it may be relevant to consider 
the evidence of gingivitis or periodontitis, such as the higher 
prevalence of bleeding gums and teeth with altered mobility. 
These findings are consistent with other studies, in which poly-
morphonuclear infiltration was observed to accompany bleed-
ing gums and periodontal disease, with increased release of 
MPO and other elements by neutrophil granules.17,43 Our find-
ings also show that the participants of the BG visited the den-
tist only when they found any concern for oral problems. 
However, the oral hygiene reported by the BG was appropriate 
and similar to those reported by the CG (frequency of tooth 
brushing and use of fluoride).
The absence of a periodontal clinical examination in this 
study limited the identification of a cause-effect relationship, 
and other factors may have been responsible for the changes in 
the biochemical markers investigated.
RYGB patients must be available periodically before and 
after surgery to assess their (1) oral health status—gingivitis 
and periodontitis (pain in the gums; bleeding gums when 
brushing and/or eating hard, dry foods; and teeth with altered 
mobility), dental caries, saliva pH and saliva flow, dental 
hypersensitivity (sensitivity to cold), and tooth pain; (2) com-
pliance with supplementation—an established form designed 
to ensure that the patients take the prescribed supplements (eg, 
vitamin C); and (3) assessment of the consumption of vitamin 
C—consumption of food sources of vitamin C (eg, fruits such 
as kiwi, orange, mango, lemon, strawberry, watermelon, and 
tangerine and vegetables such as broccoli, tomatoes, cauli-
flower, potato, spinach, and cabbage), which, beyond contrib-
uting to without disease periodontium, is a potent water-soluble 
antioxidant.
This is a novelty study to reinforce the importance of dental 
care for obese patients undergoing gastric bypass surgery 
because the standards of care for this population in Brazil and 
other countries, according to the consensus, do not include 
dentist visits. In fact, visiting the dentist as a preventive mea-
sure would benefit oral health and its complications following 
surgery.
Our results demonstrated that vitamin C deficiency and 
increased vomiting after gastric bypass for morbid obesity may 
contribute to increased periodontal disease. The fact that it is 
impossible to determine which factor or factors (diet, poor 
compliance with supplementation, vomiting, poor oral 
hygiene) contributed to the dental problems in these patients is 
a shortcoming of the report.
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